Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,556.37
(
-0.37%
)
US TECH 100
23,547.20
(
0.12%
)
Dow Jones
46,124.06
(
-0.18%
)
Brent Oil
95.63
(
-0.90%
)
Bitcoin
70,657.00
(
0.20%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Double_Bagel post# 177171

Wednesday, 04/23/2014 2:58:54 PM

Wednesday, April 23, 2014 2:58:54 PM

Post# of 257275

If VRUS was worth $11 Billion, is it unreasonable for ENTA to be worth $5 Billion?

Not a proper comparison. VRUS owned the full worldwide rights to Sovaldi at the time it was acquired, while ENTA has licensed its main asset, ABT-450, to ABBV in return for milestone payments and a royalty stream on a portion of a 3-drug regimen.

VRUS, when it was acquired, was not as far along as ENTA is now.

True, but this is outweighed by the point mentioned above.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today